<MedlineCitation Status="Completed">
<MedlineID>10011169</MedlineID>
<PMID>311204</PMID>
<DateCreated>
<Year>1979</Year>
<Month>04</Month>
<Day>28</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>04</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0004-3591</ISSN>
<JournalIssue>
<Volume>22</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1979</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus.</ArticleTitle>
<Pagination>
<MedlinePgn>226-35</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Antibodies to dsDNA, tested with circular DNA in the Farr assay, are specific for systemic lupus erythematosus. A longitudinal study showed a clear relation between the clinical state, the anti-dsDNA titer (expressed in units), and the C1q and C3 levels: when anti-dsDNA levels remained high, no exacerbations were observed. A sharp drop in anti-dsDNA, usually preceded by a rise, was related to a serious exacerbation. Only during the exacerbation when both C1q and C3 were very low was renal involvement seen.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Swaak</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Author>
<Author>
<LastName>Aarden</LastName>
<ForeName>L A</ForeName>
<Initials>LA</Initials>
</Author>
<Author>
<LastName>Statius van Eps</LastName>
<ForeName>L W</ForeName>
<Initials>LW</Initials>
</Author>
<Author>
<LastName>Feltkamp</LastName>
<ForeName>T E</ForeName>
<Initials>TE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Arthritis Rheum</MedlineTA>
<NlmUniqueID>0370605</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antibodies, Antinuclear</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Complement 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Complement 2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Circular</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-49-2</RegistryNumber>
<NameOfSubstance>DNA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Antibodies, Antinuclear</DescriptorName>
<QualifierName>analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Centrifugation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Complement 1</DescriptorName>
<QualifierName>analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Complement 2</DescriptorName>
<QualifierName>analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>DNA</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>DNA, Circular</DescriptorName>
<QualifierName>diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>DNA, Viral</DescriptorName>
<QualifierName>diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Kidney</DescriptorName>
<QualifierName>physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Kidney Function Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Lupus Erythematosus, Systemic</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName>immunology</QualifierName>
<QualifierName>physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Precipitation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Prognosis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
